MWV Episode 80 - Harald zur Hausen - Human Papilloma Virus (HPV)

submitted by: MicrobeWorld
Vincent Racaniello speaks with Professor Harald zur Hausen, recipient of the 2013 Society for General Microbiology Prize Medal for "work that has had a far-reaching impact beyond microbiology." Professor zur Hausen talks about the beginnings of his work on the human papilloma virus (HPV) starting in 1972 with a group he setup to look at the "isolation and characterization of the viruses in genital warts." This group would lead to the discovery of HPV 16 and 18 (the leading cause of...

MWV Episode 76 - Jeffrey Almond - Vaccine Development

submitted by: MicrobeWorld
Dr. Jeffrey Almond began his career as an academic virologist studying influenza. Eventually Jeffrey started his own lab and began studying picornaviruses working on an oral polio vaccine strain. Following twenty years in academics including major contributions in the eradication of polio worldwide, Jeffrey transitioned into a career in industry working on vaccine development at Sanofi Pasteur. In March of 2013, Jeffrey was at the Society for General Microbiology's Spring conference to...

New solution for therapeutic cancer vaccine failure

submitted by: mdanderson
http://www.mdanderson.org/newsroom/news-releases/2013/cancer-vaccines-ch... Vaccines designed to turn the immune system against cancer have been logically constructed and tested against many cancers. Almost all have failed or shown minimal effect. They spark creation of killer T cells against the cancer, but generally have little effect on tumors, both in patients and mouse models. Willem Overwijk, Ph.D., and colleagues at MD Anderson discovered that a common vaccine component is...

Natalie Prystajecky: Norovirus (MWV65)

submitted by: MicrobeWorld
In episode 65 of MicrobeWorld Video, Dr. Stan Maloy talks with Natalie Prystajecky Ph.D., Environmental Public Health Microbiologist, BCCDC Public Health Microbiology and Reference Laboratory, about her work with norovirus. This episode was filmed at the American Association for the Advancement of Science Meeting in Vancouver, Canada on February 16th, 2012. Norovirus is the leading cause of acute gastroenteritis in the world. In the U.S. norovirus accounts for up to sixty percent of all...

Informed Consent: Subsequent visit in Series - 4 months

submitted by: bccdc

ImmunizeBC instructional video for health professionals about informed consent prior to immunization - subsequent visit in series - 4 months

Informed Consent Prior to Immunization: Initial Visit in Series: Parent has reviewed standard information

submitted by: bccdc

ImmunizeBC instructional video for health professionals - Informed Consent Prior to Immunization: Initial Visit in Series: Parent has reviewed standard information

Informed Consent Prior to Immunization: Initial Visit in Series: Parent has not reviewed standard information

submitted by: bccdc

ImmunizeBC instructional video about Informed Consent Prior to Immunization - initial visit in series (i.e 2 months) where parent has not reviewed standard information.

Informed Consent: Mature Minor

submitted by: bccdc

ImmunizeBC instructional Informed Consent mature minor video for health professionals.

Informed Consent: Initial Vaccine Visit and Subsequent In Series 12 Months

submitted by: bccdc

ImmunizeBC instructional videos for health professionals on the informed consent process for the initial vaccine visit and subsequent 12 month visit.

Diane Harper: HPV Vaccine Efficacy (MWV52)

submitted by: MicrobeWorld
In episode 52 of MicrobeWorld Video, filmed at the American Association for the Advancement of Science Meeting in Washington, D.C., on February 18, 2011, Dr. Stan Maloy talks with Diane Harper, M.D., M.P.H, Professor in the departments of Community and Family Medicine, Obstetrics and Gynecology, and Informatics and Personalized Health at the University of Missouri-Kansas City. Harper played a critical role in the clinical studies associated with the HPV vaccines and has voiced concerns over...